Trial intelligence / Profile preview

Scaphoid non-union repair with collagen/PGA scaffold and autologous bone marrow mesenchymal stem cells

IRCT20181222042074N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Apr 2019
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Phase 3, open-label trial of autologous bone-marrow mesenchymal stem cells in scaphoid nonunion (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: The rate of bone formation and The rate of callus tissue formation. Started Apr 2019; status: completed.

02

Drugs

autologous bone-marrow mesenchymal stem cells
03

Conditions

scaphoid nonunion

Beyond the preview

Go deeper on IRCT20181222042074N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181222042074N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call